Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Current Liabilities (2016 - 2026)

Veracyte's Total Current Liabilities history spans 14 years, with the latest figure at $59.9 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 23.78% to $59.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $59.9 million, a 23.78% decrease, with the full-year FY2025 number at $59.9 million, down 23.78% from a year prior.
  • Total Current Liabilities hit $59.9 million in Q4 2025 for Veracyte, down from $72.2 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for VCYT hit a ceiling of $78.6 million in Q4 2024 and a floor of $32.7 million in Q1 2021.
  • Historically, Total Current Liabilities has averaged $61.1 million across 5 years, with a median of $60.6 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: soared 282.28% in 2021 and later decreased 23.78% in 2025.
  • Tracing VCYT's Total Current Liabilities over 5 years: stood at $64.2 million in 2021, then fell by 2.4% to $62.6 million in 2022, then decreased by 2.19% to $61.2 million in 2023, then increased by 28.4% to $78.6 million in 2024, then decreased by 23.78% to $59.9 million in 2025.
  • Business Quant data shows Total Current Liabilities for VCYT at $59.9 million in Q4 2025, $72.2 million in Q3 2025, and $76.4 million in Q2 2025.